Octagon Research Solutions (US), a provider of software and services to the life sciences industry, has appointed Terek Peterson director of clinical programming. He previously served as senior manager of statistical programming global biometrics for Shire.
Octagon Research Solutions (US), a provider of software and services to the life sciences industry, has appointed Terek Peterson director of clinical programming. He previously served as senior manager of statistical programming global biometrics for Shire.
Create an account to read this article
Already a subscriber?
Set to merge with Beckley Psytech, Atai will focus on psychedelic candidates for treatment-resistant depression while Recognify will analyze Phase IIb data for possible next steps.
A single 15% tariff rate on imports from Europe includes pharmaceuticals, but it remains unclear if the trade deal will exclude generics or if Trump will offer a grace period.
Comes Days After PDUFA Pushback For GSK's Blenrep.
After “intense negotiations”, Bavarian Nordic’s board plans to recommend a DKK19bn ($2.98bn) offer by private equity firms Nordic Capital and Permira to take the company private.
Comes Days After PDUFA Pushback For GSK's Blenrep.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
After “intense negotiations”, Bavarian Nordic’s board plans to recommend a DKK19bn ($2.98bn) offer by private equity firms Nordic Capital and Permira to take the company private.
